SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-12-061483
Filing Date
2012-02-15
Accepted
2012-02-14 17:46:36
Documents
1
Group Members
AARON DAVIDSONANTHONY TAMERH.I.G.-GPII, INC.SAMI MNAYMNEH

Document Format Files

Seq Description Document Type Size
1 SC 13G d300999dsc13g.htm SC 13G 148922
  Complete submission text file 0001193125-12-061483.txt   150564
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86177 | Film No.: 12613166
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1450 BRICKELL AVENUE 31ST FLOOR MIAMI FL 33131
Business Address 1450 BRICKELL AVENUE 31ST FLOOR MIAMI FL 33131 919-313-4760
H.I.G. Ventures - Tranzyme, LLC (Filed by) CIK: 0001515804 (see all company filings)

IRS No.: 980473120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G